Literature DB >> 9615107

[Generalized pseudoxanthoma elasticum combined with vitamin K dependent clotting factors deficiency].

C Le Corvaisier-Pieto1, P Joly, E Thomine, G Lair, P Lauret.   

Abstract

INTRODUCTION: Pseudoxanthoma elasticum is a connective tissue disease currently classed in 4 forms. Two forms are inherited via dominant autosomal transmission and the other two via recessive autosomal transmission. The generalized form of pseudoxanthoma elasticum is the most uncommon form and corresponds to recessive type II. Clinical manifestations include the typical generalized "peau d'orange" skin associated with hyperlaxity of the skin. Usually, there is no systemic manifestation. CASE REPORT: We report a case of a patient with generalized pseudoxanthoma elasticum associated with deficiency of vitamin-K dependent factors II, VII, IX, and X. A search for other causes of vitamin-K dependent factor deficiency was negative. DISCUSSION: The association of generalized pseudoxanthoma elasticum with deficiency of vitamin-K dependent clotting factors has been reported previously in very rare cases and is probably not fortuitous. It could led to the definition of a sub-group of recessive autosomal pseudoxanthoma elasticum.

Entities:  

Mesh:

Year:  1996        PMID: 9615107

Source DB:  PubMed          Journal:  Ann Dermatol Venereol        ISSN: 0151-9638            Impact factor:   0.777


  9 in total

Review 1.  ABCC6 as a target in pseudoxanthoma elasticum.

Authors:  András Váradi; Zalán Szabó; Viola Pomozi; Hugues de Boussac; Krisztina Fülöp; Tamás Arányi
Journal:  Curr Drug Targets       Date:  2011-05       Impact factor: 3.465

2.  Co-existent pseudoxanthoma elasticum and vitamin K-dependent coagulation factor deficiency: compound heterozygosity for mutations in the GGCX gene.

Authors:  Qiaoli Li; Leon J Schurgers; Ann C M Smith; Maria Tsokos; Jouni Uitto; Edward W Cowen
Journal:  Am J Pathol       Date:  2008-12-30       Impact factor: 4.307

3.  Mutations in the GGCX and ABCC6 genes in a family with pseudoxanthoma elasticum-like phenotypes.

Authors:  Qiaoli Li; Dorothy K Grange; Nicole L Armstrong; Alison J Whelan; Maria Y Hurley; Mark A Rishavy; Kevin W Hallgren; Kathleen L Berkner; Leon J Schurgers; Qiujie Jiang; Jouni Uitto
Journal:  J Invest Dermatol       Date:  2008-09-18       Impact factor: 8.551

4.  Modifier genes in pseudoxanthoma elasticum: novel insights from the Ggcx mouse model.

Authors:  Alain Hovnanian
Journal:  J Mol Med (Berl)       Date:  2010-02-11       Impact factor: 4.599

Review 5.  Pseudoxanthoma elasticum: clinical phenotypes, molecular genetics and putative pathomechanisms.

Authors:  Qiaoli Li; Qiujie Jiang; Ellen Pfendner; András Váradi; Jouni Uitto
Journal:  Exp Dermatol       Date:  2008-10-22       Impact factor: 3.960

Review 6.  Pseudoxanthoma elasticum and skin: Clinical manifestations, histopathology, pathomechanism, perspectives of treatment.

Authors:  Barbara Marconi; Ivan Bobyr; Anna Campanati; Elisa Molinelli; Veronica Consales; Valerio Brisigotti; Marina Scarpelli; Stefano Racchini; Annamaria Offidani
Journal:  Intractable Rare Dis Res       Date:  2015-08

7.  Retinitis pigmentosa, cutis laxa, and pseudoxanthoma elasticum-like skin manifestations associated with GGCX mutations.

Authors:  Ariana Kariminejad; Bita Bozorgmehr; Abdolhamid Najafi; Atefeh Khoshaeen; Maryam Ghalandari; Hossein Najmabadi; Mohamad H Kariminejad; Olivier M Vanakker; Mohammad J Hosen; Fransiska Malfait; Daniela Quaglino; Ralph J Florijn; Arthur A B Bergen; Raoul C Hennekam
Journal:  J Invest Dermatol       Date:  2014-04-16       Impact factor: 8.551

Review 8.  From variome to phenome: Pathogenesis, diagnosis and management of ectopic mineralization disorders.

Authors:  Eva Yg De Vilder; Olivier M Vanakker
Journal:  World J Clin Cases       Date:  2015-07-16       Impact factor: 1.337

9.  New insights into the pathogenesis of pseudoxanthoma elasticum and related soft tissue calcification disorders by identifying genetic interactions and modifiers.

Authors:  Doris Hendig; Cornelius Knabbe; Christian Götting
Journal:  Front Genet       Date:  2013-06-19       Impact factor: 4.599

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.